Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol

Autor: Sydes, M R, Spears, M R, Mason, M D, Clarke, N W, Dearnaley, D P, de Bono, J S, Attard, G, Chowdhury, S, Cross, W, Gillessen, S, Malik, Z I, Jones, R, Parker, C C, Ritchie, A W S, Russell, J M, Millman, R, Matheson, D, Amos, C, Gilson, C, Birtle, A, Brock, S, Capaldi, L, Chakraborti, P, Choudhury, A, Evans, L, Ford, D, Gale, J, Gibbs, S, Gilbert, D C, Hughes, R, McLaren, D, Lester, J F, Nikapota, A, O’Sullivan, J, Parikh, O, Peedell, C, Protheroe, A, Rudman, S M, Shaffer, R, Sheehan, D, Simms, M, Srihari, N, Strebel, R, Sundar, S, Tolan, S, Tsang, D, Varughese, M, Wagstaff, J, Parmar, M K B, James, N D

Publikováno v: Annals of Oncology
Sydes, M R, Spears, M R, Mason, M D, Clarke, N W, Dearnaley, D P, de Bono, J S, Attard, G, Chowdhury, S, Cross, B, Gillessen, S, Malik, Z, Jones, R, Parker, C, Ritchie, A W S, Russell, J M, Millman, R, Matheson, D, Amos, C, Gilson, C, Birtle, A, Brock, S, Capaldi, L, Chakraborti, P, Choudhury, A, Evans, L, Ford, D, Gale, J, Gibbs, S, Gilbert, D, Hughes, R, McLaren, D, Lester, J, Nikapota, A, O'Sullivan, J, Parikh, O, Peedell, C, Protheroe, A, Rudman, S M, Shaffer, R, Sheehan, D, Simms, M, Srihari, N, Strebel, R, Sundar, S, Tolan, S, Tsang, D, Varughese, M, Wagstaff, J, Parmar, M K B & James, N D 2018, ' Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol ', Annals of Oncology . https://doi.org/10.1093/annonc/mdy072
Sydes, M R, Spears, M, Mason, M, Clarke, N, Dearnaley, D P, de Bono, J, Attard, G, Chowdhury, S, Cross, W, Gillessen Sommer, S, Malik, Z, Jones, R, Parker, C, Ritchie, A W S, Russell, J M, Millman, R, Matheson, D, Amos, C, Gilson, C, Birtle, A, Brock, S, Capaldi, L, Chakraborti, P, Choudhury, A, Evans, L, Ford, D, Gale, J, Gibbs, S, Gilbert, D C, Hughes, R, McLaren, D, Lester, J, Nikapota, A, O'Sullivan, J, Parikh, O, Peedell, C, Protheroe, A, Rudman, S, Shaffer, R, Sheehan, D, Simms, M, Srihari, N, Strebel, R, Sundar, S, Tolan, S, Tsang, D, Varughese, M, Wagstaff, J, Parmar, M K B & James, N 2018, ' Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer : directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol ', Annals of Oncology, vol. 29, no. 5, pp. 1235-1248 . https://doi.org/10.1093/annonc/mdy072

Background Adding abiraterone acetate with prednisolone (AAP) or docetaxel with prednisolone (DocP) to standard-of-care (SOC) each improved survival in systemic therapy for advanced or metastatic prostate cancer: evaluation of drug efficacy: a multi-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4ec65067a6609dcbd43d7690a573f6a6

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

What are the optimal systemic treatments for men with metastatic, hormone-sensitive prostate cancer? A STOPCaP systematic review and network meta-analysis

Autor: Vale, C. L., Fisher, D. J., Carpenter, J., White, I. R., Burdett, S., Clarke, N. W., Fizazi, K., Gwenaelle Gravis, James, N. D., Mason, M. D., Parmar, M. K., Rydzewska, L. H., Sweeney, C. J., Spears, M. R., Sydes, M. R., Tierney, J. F.

Publikováno v: Web of Science

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b52d0a1719d10c23c2e5f8f679dd5b87
https://publons.com/publon/9705578/

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.